Results 231 to 240 of about 18,522,447 (385)

Mortality risk attributable to high and low ambient temperature: a multicountry observational study

open access: yesThe Lancet, 2015
A. Gasparrini   +21 more
semanticscholar   +1 more source

Lactoferrin treatment activates acetylcholinesterase, decreasing acetylcholine levels in non‐small cell lung cancer (NSCLC) cell culture supernatants, inhibiting cell survival

open access: yesFEBS Open Bio, EarlyView.
Representation of the suggested mode of action of lactoferrin (Lf) in nonsmall cell lung cancer (NSCLC) A549 cells. Lf induces activation of caspase‐3 by activating p53 and AChE leading to decreased ACh concentrations. In turn, ACh signaling leads to activation of VEGF and AKT and blocking of caspase‐3.
Stuti Goel   +9 more
wiley   +1 more source

Controversies about refrigeration of dental adhesives: a review. [PDF]

open access: yesBDJ Open
El-Maksoud OA   +3 more
europepmc   +1 more source

Humidity-gated, temperature-responsive photonic infrared reflective broadband coatings

open access: hybrid, 2019
Ellen P. A. van Heeswijk   +3 more
openalex   +2 more sources

Recent advances in high‐loading catalysts for low‐temperature fuel cells: From nanoparticle to single atom

open access: gold, 2021
Lixiao Shen   +8 more
openalex   +1 more source

Temperature Monitoring [PDF]

open access: yesAnaesthesia and Intensive Care, 2010
C, Ball, R N, Westhorpe
openaire   +2 more sources

Indoleamine 2,3‐dioxygenase 1 inhibition reverses cancer‐associated fibroblast‐mediated immunosuppression in high‐grade serous ovarian cancer

open access: yesFEBS Open Bio, EarlyView.
CAF‐mediated immunosuppression in ovarian cancer is driven by IDO1, reducing T‐cell function. Inhibiting IDO1 restores T‐cell proliferation and cytotoxicity, increases cancer cell apoptosis, and may help overcome CAF‐induced immune suppression in high‐grade serous ovarian cancer. Targeting IDO1 may improve antitumor immunity.
Hyewon Lee   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy